GH
Guardant Health, Inc. · Healthcare · Medical - Diagnostics & Research
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 139 | +11 | 93.68M | $13.96B | +17 | −5 |
| Q1 2026 | 130 | -8 | 97.95M | $8.77B | +5 | −14 |
| Q4 2025 | 137 | +1 | 99.79M | $9.86B | +2 | — |
| Q3 2025 | 22 | +1 | 50.89M | $3.18B | +2 | −2 |
| Q2 2025 | 19 | -1 | 51.15M | $2.66B | — | −1 |
| Q1 2025 | 17 | -1 | 25.07M | $1.07B | — | −1 |
| Q4 2024 | 18 | +2 | 25.10M | $766.76M | +2 | — |
| Q3 2024 | 15 | +1 | 25.31M | $580.70M | +2 | −1 |
| Q2 2024 | 14 | — | 24.13M | $697.01M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 6.09M | — | $175.97M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 6.09M | — | $175.97M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 6.09M | — | $175.97M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 6.09M | — | $175.97M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 3.51M | — | $101.33M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 3.51M | — | $101.33M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 3.51M | — | $101.33M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 3.51M | — | $101.33M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 3.29M | — | $95.04M | 0.1% | n/c | 1 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 3.29M | — | $95.04M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | Geode Capital Management ✦ (pasif) | 2.79M | — | $80.66M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Geode Capital Management ✦ (pasif) | 2.79M | — | $80.66M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Millennium Management ✦ | 2.14M | — | $61.67M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Point72 Asset Management ✦ | 1.82M | — | $52.42M | 0.2% | n/c | 1 | SEC ↗ |
| 15 | Norges Bank ✦ (pasif) | 1.38M | — | $39.96M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 1.38M | — | $39.73M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 1.38M | — | $39.73M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 814.52K | — | $23.52M | 0.1% | n/c | 1 | SEC ↗ |
| 19 | ARK Investment Management ✦ | 453.59K | — | $13.10M | 0.1% | n/c | 1 | SEC ↗ |
| 20 | Adage Capital Partners ✦ | 299.80K | — | $8.66M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 84.75K | — | $2.45M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | PRIMECAP Management ✦ | 66.18K | — | $1.91M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Bridgewater Associates ✦ | 20.20K | — | $583,405 | 0.0% | n/c | 1 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 481 pemegang, 137.05M saham, $11.53B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer, Director · 20.89K lbr · $3.53M
Officer, Director · 7.59K lbr · $1.29M
Officer, Director · 9.02K lbr · $1.52M
Director · 116 lbr · $18,148
Officer · 13.25K lbr · $2.20M
Officer · 3.70K lbr · $605,286
Officer · 9.93K lbr · $1.63M
Officer · 19.01K lbr · $3.14M
Officer · 400 lbr · $67,168
Officer · 3.46K lbr · $579,639
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi